Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Next Science.
RELATED STOCKHEAD STORIES
News
In Case You Missed It: A coal takeover attempt and gold plays round out the day
Experts
Dr Boreham’s Crucible: With a US focus, can Next Science’s new leaders stem the bleeding?
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: An unlikely bunch of small cap heroes bring it home for the ASX on Tuesday
Health & Biotech
ASX Health Stocks: Cyclopharm confident after US FDA inspection; Anteris a step closer to FDA approval
Health & Biotech
ASX Health Stocks: Sub $50m market cap Austco nabs $7.4m contract, the biggest in its history
News
Market Highlights: Wall Street rallies on China stimulus; expert predicts H2 stock market outlook for Australia
Health & Biotech
ASX Health Stocks: Patrys wins fresh grant, IDT does not and Next Science is off to sell stuff in Canada
News
Closing Bell: Resources reboot puts fresh socks on small cap index
Health & Biotech
ScoPo’s Powerplays: Case of courage under fire for ASX health stocks
Health & Biotech
Check Up: Moderna trials mRNA-based HIV vaccine, while these ASX biotechs get patents
Health & Biotech
ASX Health Stocks: USCOM jumps 12pc on China patent, while Next Science gets TGA nod
Health & Biotech
ASX Health Stocks: AFT Pharma jumps 13pc on FDA submission, Imugene up 10pc on CAR-T progress
News
Last Orders: Energy and health stocks send the ASX retreating again
News
Last Orders: ASX finishes higher, but only slightly
Director Trades
Directors’ Trades: A trio of directors from this copper stock chipped in amidst the boom
News
